Mitchel Williams
Neurology with Special Qualifications in Child Neurology · Detroit, MINPI 1194979567
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Neurelis, Inc. at 43.0% of the total. That places this record below the midpoint for neurology with special qualifications in child neurology clinicians in MI, where the typical reported total is $624.
Across 20 payments — averaging $22.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurelis, Inc.$193
- UCB, Inc.$71
- Sanofi$36
- Aquestive Therapeutics, Inc.$28
- Livanova USA, Inc.$28
- Catalyst Pharmaceuticals, Inc.$25
- plus $67 from 4 others
Across 10 payments — averaging $31,494 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$281K
- Sarepta Therapeutics, Inc.$34K
What the payments were for
- Food & beverage$449100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurelis, Inc. | 8 | $193 |
| UCB, Inc. | 3 | $71 |
| Sanofi | 1 | $36 |
| Aquestive Therapeutics, Inc. | 2 | $28 |
| Livanova USA, Inc. | 1 | $28 |
| Catalyst Pharmaceuticals, Inc. | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Upsher-smith Laboratories LLC | 1 | $16 |
| Eisai Inc. | 1 | $16 |
How this compares
$449 in reported general payments places this provider in the 40th percentile of 62 neurology with special qualifications in child neurology providers in Michigan.
See all neurology with special qualifications in child neurology providers in Michigan →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine | 14 | $166 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Detroit
- Gyula AcsadiDetroit$86K
- Michelle FigueroaDetroit$57K
- Aimee LuatDetroit$12K
- Eishi AsanoDetroit$5K
- Jayaprakash GosalakkalDetroit$3K
- Daniela TaposDetroit$3K
- Beata RuprechtDetroit$2K
- Carla WatsonDetroit$1K
- Naznin MahmoodDetroit$972
- Fatema SerajeeDetroit$910
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.